Table 1 Characteristics of the studies included in the present meta-analysis
From: Circular RNA circSMARCA5 is a prognostic biomarker in patients with malignant tumor: a meta-analysis
Study | Year | Region | Cancer type | No. of cases | Expression | Follow-up time (month) | Detection Method | Survival outcome | NOS score |
|---|---|---|---|---|---|---|---|---|---|
Barbagallo et al [16] | 2019 | Italy | glioblastoma | 31 | Low | ≥ 40 | RT-qPCR | OS, PFS | 6 |
Cai et al [15] | 2019 | China | gastric cancer | 60 | Low | ≥ 40 | RT-qPCR | OS, DFS | 7 |
Liu et al [17] | 2019 | China | multiple myeloma | 105 | Low | ≥ 40 | RT-qPCR | OS, PFS | 6 |
Lu et al [14] | 2020 | China | intrahepatic cholangiocarcinoma | 92 | Low | ≥ 60 | RT-qPCR | OS | 8 |
Miao et al [18] | 2020 | China | colorectal cancer | 45 | Low | ≥ 100 | RT-qPCR | OS | 8 |
Tong et al [13] | 2020 | China | non-small cell lung carcinoma | 460 | Low | ≥ 96 | RT-qPCR | OS, DFS | 8 |
Yu et al [8] | 2018 | China | hepatocellular carcinoma | 40 | Low | ≥ 60 | RT-qPCR | OS, RFS | 8 |